Literature DB >> 30654936

Recruitment of the protein phosphatase-1 catalytic subunit to promoters by the dual-function transcription factor RFX1.

Yoav Lubelsky1, Yosef Shaul2.   

Abstract

RFX proteins are a family of conserved DNA binding proteins involved in various, essential cellular and developmental processes. RFX1 is a ubiquitously expressed, dual-activity transcription factor capable of both activation and repression of target genes. The exact mechanism by which RFX1 regulates its target is not known yet. In this work, we show that the C-terminal repression domain of RFX1 interacts with the Serine/Threonine protein phosphatase PP1c, and that interaction with RFX1 can target PP1c to specific sites in the genome. Given that PP1c was shown to de-phosphorylate several transcription factors, as well as the regulatory C-terminal domain of RNA Polymerase II the recruitment of PP1c to promoters may be a mechanism by which RFX1 regulates the target genes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Co-repressor; PP1; Protein phosphatase; RFX1; Transcription repression

Mesh:

Substances:

Year:  2019        PMID: 30654936     DOI: 10.1016/j.bbrc.2019.01.011

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  RTNduals: an R/Bioconductor package for analysis of co-regulation and inference of dual regulons.

Authors:  Vinicius S Chagas; Clarice S Groeneveld; Kelin G Oliveira; Sheyla Trefflich; Rodrigo C de Almeida; Bruce A J Ponder; Kerstin B Meyer; Steven J M Jones; A Gordon Robertson; Mauro A A Castro
Journal:  Bioinformatics       Date:  2019-12-15       Impact factor: 6.937

Review 2.  Phosphoproteomics Meets Chemical Genetics: Approaches for Global Mapping and Deciphering the Phosphoproteome.

Authors:  Jan Jurcik; Barbara Sivakova; Ingrid Cipakova; Tomas Selicky; Erika Stupenova; Matus Jurcik; Michaela Osadska; Peter Barath; Lubos Cipak
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

Review 3.  RFX1: a promising therapeutic arsenal against cancer.

Authors:  Joby Issac; Pooja S Raveendran; Ani V Das
Journal:  Cancer Cell Int       Date:  2021-05-08       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.